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Periostin increases
migration and proliferation
of human periodontal
ligament fibroblasts
challenged by tumor
necrosis factor-a and
Porphyromonas gingivalis
lipopolysaccharides
Padial-Molina M, Volk SL, Rios HF. Periostin increases migration and
proliferation of human periodontal ligament fibroblasts challenged by tumor
necrosis factor-a and Porphyromonas gingivalis lipopolysaccharides. J Periodont
Res 2014; 49: 405–414. © 2013 John Wiley & Sons A/S. Published by John Wiley
& Sons Ltd
Background: In the chronic established periodontal lesion, the proliferation and
migration potential of periodontal ligament (PDL) cells are signiﬁcantly com-
promised. Thus, the progressive loss of tissue integrity is favored and normal
healing and regeneration compromised. Periostin, a known PDL marker, modu-
lates cell–matrix interactions, cell behavior, as well as the matrix biomechanics
and PDL homeostasis.
Objective: To evaluate whether periostin restores the regenerative potential of
PDL cells in terms of proliferation, migration, and activation of survival signal-
ing pathways after being challenged by Porphyromonas gingivalis lipopolysaccha-
rides and tumor necrosis factor alpha a.
Methods: Human PDL (hPDL) cells were cultured under diﬀerent conditions:
control, periostin (50 or 100 ng/mL), and ﬁbroblast growth factor 2 (10 ng/mL)
to evaluate cell proliferation (by Ki67), cell migration (by scratch assays) and
PI3K/AKT/mTOR pathway activation (by western blot analyses of total AKT,
phospho-AKT and PS6). A diﬀerent set of cultures was challenged by adding
tumor necrosis factor alpha a (10 ng/mL) and P. gingivalis lipopolysaccharides
(200 ng/mL) to evaluate the eﬀects of periostin as described above.
Results: Periostin signiﬁcantly increased cell proliferation (twofold), migration
(especially at earlier time points and low dose) and activation of survival signal-
ing pathway (higher phosphorylation of AKT and PS6). Furthermore, periostin
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promoted similar cellular eﬀects even after being challenged with proinﬂamma-
tory cytokines and bacterial virulence factors.
Conclusion: Periostin acts as an important modulator of hPDL cell–matrix
dynamics. It modulates hPDL proliferation, migration and PI3K/AKT/mTOR
pathway. It also helps in overcoming the altered biological phenotype that
chronic exposure to periodontal pathogens and proinﬂammatory cytokines pro-
duce in hPDL cells.
The tooth-supporting apparatus (i.e.
periodontium) includes the alveolar
bone, periodontal ligament (PDL),
cementum and gingiva. The periodon-
tium is a highly specialized adaptive
dynamic tissue able to sustain diﬀer-
ent microbiological, inﬂammatory and
mechanical challenges through a num-
ber of complex molecular events
involving growth factors, transcrip-
tion factors and extracellular matrix
(ECM) proteins (1,2).
In humans, microbially induced
inﬂammatory periodontal diseases are
the primary initiators that disrupt the
functional and structural integrity of
the periodontium. Diﬀerent forms of
periodontal diseases virtually aﬀect the
entire population (3,4), which consti-
tutes a true public health concern.
Moreover, once the periodontal break-
down occurs, the ideal restoration (i.e.
regeneration) of its original structure,
properties and function is a signiﬁcant
challenge in the clinical setting (5).
Eﬀorts have been made on regenerat-
ing lost alveolar bone. However,
regeneration of the lost periodontium
involves the formation of all tooth-
supporting structures in a temporal
and spatial progress (6). Although the
exact cellular and molecular events
are still not clear, speciﬁc cells must
ﬁrst migrate to the healing area and
proliferate. This process is mediated
and coordinated by soluble factors,
other cells, ECM and matricellular
proteins. Normal mechanical stimuli
will increase and promote an orga-
nized ECM synthesis and organization
as well as cementum and bone forma-
tion and maturation. Once those struc-
tures are established, PDL ﬁbers are
organized and oriented, connecting the
tooth to the alveolar bone (7).
In this context, matricellular mole-
cules within the PDL provide signals
to the constituent cell populations to
modulate their phenotype to maintain
tissue homeostasis. Periostin (gene
POSTN), a secreted adhesion mole-
cule highly speciﬁc to the PDL,
mainly secreted by ﬁbroblasts (8), is
essential for the periodontal tissue
integrity and homeostasis and plays
an important role in tooth develop-
ment and eruption processes (2,9,10).
Periostin is induced by biomechanical
stimuli via transforming growth-ß1
signaling (2) and regulates collagen
ﬁbrillogenesis and tissue strength
(11,12). However, it is reduced by the
eﬀect of inﬂammatory cytokines and
bacterial virulence factors (13). Levels
of periostin are inversely correlated to
the extent of alveolar bone loss (14).
Periostin has been suggested to modu-
late the connective tissue repair and
remodeling in cardiac tissue (15) and
skin (16) by the activation of the cell
survival AKT/PKB pathway (17). It
has also shown an increase in smooth
muscle cell migration via avb3 and
avb5-integrins and phosphorylation
of FAK (18). However, the role of
periostin in periodontal regeneration
and PDL cells has still not been
described.
Therefore, the aim of this study
was to analyze the eﬀects of recombi-
nant periostin supplementation on the
regenerative potential of human PDL
(hPDL) cells in terms of cell prolifera-
tion and migration capacities as well
as the activation of the PI3K/AKT/
mTOR survival signaling pathway.
The ability of periostin to recover cell
activity after being challenged by pro-
inﬂammatory cytokines and bacterial
virulence factors was also analyzed.
Material and methods
Cell populations
Primary hPDL cells were character-
ized and used as previously reported
(13). The use of human cells was
approved by the University of Michi-
gan Institutional Review Board. Cells
were maintained in Dulbecco’s modi-
ﬁed Eagle’s medium (Gibco, Life
Technologies Corporation, Grand
Island, NY, USA) supplemented with
10% fetal bovine serum (Gibco), anti-
biotics (100 units/mL penicillin and
100 lg/mL streptomycin), antifungal
(1 : 1000 amphotericin B) and 2 mM
glutamine, at 37°C in a humidiﬁed
atmosphere of 95% air/5% CO2. Cells
were removed from the growth sur-
face with a trypsin solution [0.25%
trypsin, 0.1% glucose, citrate-saline
buﬀer (pH 7.8); Gibco] and subse-
quently used for experiments. Cells
were used between passages 5 and 8
for experiments.
Cell culture conditions
Cells were seeded in six-well plates. At
70% conﬂuence, media was substi-
tuted with starving media (no fetal
bovine serum). After 24 h, wells were
assigned to four diﬀerent groups and
media changed and supplemented
accordingly: C (control), P100 (recom-
binant human periostin, 100 ng/mL;
R&D Systems Inc., Minneapolis, MN,
USA), P50 (periostin, 50 ng/mL), and
ﬁbroblast growth factor (FGF)-2 as
positive control (recombinant human
FGF-2, 10 ng/mL; Gibco).
To investigate the capacities of
recombinant periostin to recover cell
capacities in a challenged environment,
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a similar set of cultures were sub-
jected to chronic exposure (4 d) to
TNF-a + P. gingivalis lipopolysaccha-
ride (LPS) (T + L: 10 ng/mL TNF-a;
Abcam Inc., Cambridge, MA, USA;
200 ng/mL P. gingivalis LPS), known
to reduce periostin expression and
extracellular deposition by hPDL
cells (13). Then, cell cultures were
subjected to starving media for 24 h
and supplemented with periostin or
FGF-2 as described above.
Three separate experiments with
the diﬀerent media supplementations
were performed in triplicate for all
primary hPDL populations for all
assays.
Analysis of cell proliferation by Ki67
For Ki67 staining, cells were seeded
into a 16-well Lab-TekTM Chamber
SlideTM System (Thermo Fisher Scien-
tiﬁc, Waltham, MA, USA) at 50%
conﬂuence. After 24 h of starving,
cells were subjected to the same con-
ditions described above. Six hours
later, the culture medium was
removed, cells were washed twice
with phosphate-buﬀered saline (PBS),
and ﬁxed in 100% cold methanol for
5 min. Cells were then washed again,
and blocked in 3% bovine serum
albumin (BSA)-PBS for 1 h. Immu-
noﬂuorescence staining for Ki67 was
performed using a mouse monoclonal
antibody to human Ki67 overnight
(1 : 100 dilution in 3% BSA-PBS;
Dako North America, Inc., Carpinte-
ria, CA, USA). The immunological
reaction was visualized by using a
secondary antibody to mouse conju-
gated with ﬂuorescein isothiocyanate
for 1 h (1 : 100 dilution in 3%
BSA-PBS). Slides were then treated
with an antifade agent containing
DAPI (ProLong Gold antifade
reagent with DAPI; Invitrogen, Life
Technologies Corporation) and cov-
ered with glass coverslips. All stained
slides were imaged using an OLYM-
PUS Fluoview 500 confocal micro-
scope (Olympus America Inc., Center
Valley, PA, USA) using the same
settings. Three images per well were
captured. Three separate experiments
with the diﬀerent media supplemen-
tations in triplicate were performed
for all primary hPDL populations.
Ki67-positive cells (green) and total
cell number (DAPI staining, blue)
were counted to calculate the mean
percentage of positive cells per group
and normalized to the control.
Scratch migration assay
A scratch-simulated wound migration
assay was performed to assess the
eﬀect of exogenous periostin supple-
mentation. hPDL cells were seeded
on to six well plates and allowed to
grow close to 95% conﬂuence. After
24 h of starving, a scratch was per-
formed along the diameter of the
well (19) and the scraped cells were
removed by washing with PBS. Fresh
culture media was added and supple-
mented with each one of the treat-
ment groups as described above.
After that, images from the same
area were taken from 0 to 48 h after
the scratch with a 6 h interval at 49.
Three separate experiments with the
diﬀerent media supplementations in
triplicate were performed for all pri-
mary hPDL populations. The scraped
area was measured by ImageJ soft-
ware (National Institute of Health,
USA; http://rsbweb.nih.gov/ij/). The
wound area over time was measured
considering the area at time 0 as
100%.
Survival pathway activation analysis
Six hours after media supplementa-
tion, supernatant was removed, cells
were washed twice with PBS and col-
lected by scraping. Cells suspended in
PBS were spun at 3500 g for 10 min
at 4°C to pellet the cells. Cell pellets
were resuspended in lysis buﬀer
(0.1 M Tris pH 6.8, 2% SDS, 1%
b-mercaptoethanol, 1 : 100 protease
inhibitor cocktail), vortexed for
5 min and incubated on ice for
30 min. The lysates were centrifuged
again (14,000 g for 10 min at 4°C)
and protein supernatants were col-
lected.
Total protein concentration was
quantiﬁed using the Quant-iT Pro-
tein Assay Kit with the Qubit Fluo-
rometer (Invitrogen, Life Technologies
Corporation). Ten lg of total protein
from each solution were run on 10%
SDS-PAGE gels (100 V, 2 h), elec-
troblotted on to PVDF membranes
(90 V, 90 min), blocked (5% milk in
TBST pH 7.4, 1 h), and immuno-
probed for phospho-S6 ribosomal
protein [1 : 1000 in 5% milk, rabbit
monoclonal to PS6 (Ser235/236) (Cell
Signaling Technology, Inc., Danvers,
MA, USA) overnight; 1 : 4000 goat
anti-rabbit IgG-horseradish peroxi-
dase (HRP) (Santa Cruz Biotechnol-
ogy, Inc., Santa Cruz, CA, USA),
1 h]. Membranes were stripped
(25 mM glycine, 1% SDS, pH 2.0,
for 2 h), blocked and immuno-
probed for phospho-AKT [1 : 1000
in 5% milk, rabbit polyclonal to
phospho-AKT (Ser473) (Cell Signal-
ing Technology) overnight; 1 : 4000
goat antirabbit IgG-HRP (Santa
Cruz Biotechnology), 1 h), stripped,
blocked and immuno-probed for
total-AKT (1 : 500 in 5% milk, rab-
bit polyclonal to pan-AKT (T308)
(Abcam) overnight; 1 : 4000 goat an-
tirabbit IgG-HRP (Santa Cruz Bio-
technology), 1 h], and stripped,
blocked, and immuno-probed again
for GAPDH [1 : 4000 in 5% milk,
goat polyclonal to GAPDH (R&D)
overnight; 1 : 4000 donkey antigoat
IgG-HRP (Santa Cruz Biotechnol-
ogy), 1 h]. Immunopositive bands
were detected by enhanced chemilu-
minescence (Thermo Fisher Scien-
tiﬁc).
Western blot band signals were
semi-quantiﬁed using ImageJ software
(National Institute of Health). Immu-
nopositive bands for each group were
adjusted by GAPDH and the intensity
fold changes normalized by assigning
a relative value of 1 to the control
group.
Statistical analysis
PASW Statistics 18.0 (SPSS Inc., Chi-
cago, IL, USA) was used for the sta-
tistical analyses. All data are
presented as the means  SEM. The
signiﬁcance of the diﬀerences among
groups was determined by using the
ANOVA test (a = 0.05). Fisher least
signiﬁcant diﬀerence test was used to
deﬁne pairwise statistical diﬀerences
(a = 0.05).
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Results
Periostin increases human
periodontal ligament proliferation,
migration and activates survival
pathways
Under non-challenged conditions,
immunoﬂuorescence staining for Ki67
proliferation marker demonstrated that
periostin 100 ng/mL (2.02  0.21),
50 ng/mL (1.99  0.18) and FGF-2
(1.92  0.20) signiﬁcantly increased
hPDL cell proliferation by approxi-
mately twofold compared to control
(1.00  0.16) (p < 0.004; p < 0.005;
p < 0.008, respectively) (Fig. 1; values
of Ki67-positive cell percentages per
group normalized to control).
hPDL cell migration analyzed by
scratch assay was signiﬁcantly acceler-
ated by the addition of periostin or
FGF-2 at every time point compared
to the control group (Fig. 2). The
highest concentration of periostin
(100 ng/mL) showed a very similar
eﬀect as that achieved by the positive
control FGF-2. Interestingly, the
addition of 50 ng/mL of periostin
showed a greater improvement, espe-
cially at earlier time points (up to
18 h), with statistically signiﬁcant
eﬀects even when compared to FGF-2
(p < 0.001) and periostin 100 ng/mL
(p < 0.003), as early as 6 h (Fig. 2B).
In terms of survival pathway acti-
vation under non-challenged condi-
tions (Fig. 3; relative values of signal
intensities compared to the control
condition), there was an increase in
detection of total AKT depending on
the groups: 1  0.55, 1.62  0.67,
2.57  1.28 and 6.75  2.08 (control,
periostin 100 ng/mL, 50 ng/mL and
FGF-2, respectively; Fig. 3B). In
terms of phosphorylation of AKT,
there was an increase in periostin
50 ng/mL and FGF-2 groups com-
pared to control and periostin 100 ng/
mL: 1  0.16, 0.47  0.1, 1.57  0.26
and 1.35  0.13 (control, periostin
100 ng/mL, 50 ng/mL and FGF-2,
respectively; Fig. 3C). The increase in
periostin 50 ng/mL and FGF-2
groups was statistically signiﬁcant
compared to periostin 100 ng/mL
(p < 0.011 for periostin 50 ng/mL;
p < 0.022 for FGF-2). Similarly, PS-6
followed the same pattern: 1  0.12,
0.1  0.03, 3.52  0.18 and 3.61 
0.06 (control, periostin 100 ng/mL,
50 ng/mL and FGF-2, respectively;
Fig. 3D). Compared to control or
periostin 100 ng/mL, phosphorylation
of protein S6 was signiﬁcantly higher
when periostin 50 ng/mL (p < 0.001)
or FGF-2 (p < 0.001) were added.
Interestingly, phosphorylation of pro-
tein S6 was signiﬁcantly lower when
periostin 100 ng/mL was added
(p < 0.005).
Periostin increases human
periodontal ligament proliferation,
migration and activates survival
pathways under challenged
conditions
Under challenged conditions, immu-
noﬂuorescence staining for Ki67 pro-
liferation marker showed that only
the addition of periostin 100 ng/mL
(1.59  0.11) and FGF-2 (1.41 
0.12) showed statistically signiﬁcant
diﬀerences compared to the control
group (1.00  0.16; p < 0.002 and
p < 0.026, respectively). However, and
more interestingly, when compared to
the TNF-a + P. gingivalis LPS group
(0.85  0.14), all groups, including
the addition of periostin 50 ng/mL
(1.31  0.08), showed statistically sig-
niﬁcant diﬀerences (p < 0.001, p <
0.008 and p < 0.003; T + L + P100,
T + L + P50 and T + L + FGF-2,
respectively; Fig. 4) (values of Ki67-
positive cell percentages per group
normalized to control).
In terms of migration, the addition
of periostin or FGF-2 improved the
eﬀects compared to TNF-a + P. gin-
givalis LPS alone (Fig. 5). Interest-
ingly, the eﬀects of periostin (50 and
100 ng/mL) were more noticeable at
earlier time points (6 h), when the
migration capacities were better
than the positive control FGF-2 com-
pared to TNF-a + P. gingivalis LPS
(p < 0.022, p < 0.045 and p = 0.224;
T + L + P100, T + L + P50 and
T + L + FGF-2, respectively). Inter-
estingly, the eﬀects of periostin under
challenged conditions improved
migration to levels similar to those
under non-challenged conditions. At
later time points (more than 24 h),
the diﬀerences between T + L + P100
and TNF-a + P. gingivalis LPS alone
were not statistically signiﬁcant. At
those time points, only the addition
of 50 ng/mL of periostin or FGF-2
showed signiﬁcant improvements
compared to TNF-a + P. gingivalis
LPS alone; those two groups (T + L
A B
Fig. 1. Ki67 proliferation analysis under non-challenged conditions. (A) Representative
image showing total cell number per image (DAPI in blue) and Ki67-positive cells (green).
Original magniﬁcation: 209. Scale bar = 50 lm. (B) Relative values of Ki67-positive cell
percentages per group normalized to control (blue). Note the approximate twofold
increase when adding periostin 100 ng/mL (green), 50 ng/mL (orange) and FGF-2 (pur-
ple). p-values compared to control: p < 0.008. n = 216 (four conditions, two cell lines,
three experiments, triplicates per condition, three images per replicate). FGF, ﬁbroblast
growth factor; hPDL, human periodontal ligament.
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+ P50 and T + L + FGF-2) were not
diﬀerent between themselves. Further-
more, the eﬀects of periostin 50 ng/
mL between 18 and 36 h were compa-
rable to the non-challenged control
group (Fig. 5B).
In terms of survival pathway acti-
vation under challenged conditions,
previous observations were markedly
evident (Fig. 6) (relative values of sig-
nal intensities compared to the con-
trol condition). In this scenario, even
though total AKT was signiﬁcantly
higher in all groups compared to the
control group (8.02  1.42, 9.22 
0.02, 8.71  0.85 and 14.5  1.025;
p < 0.003, p < 0.001, p < 0.002 and
p < 0.001; T + L, T + L + P100,
T + L + P50 and T + L + FGF-2,
respectively; Fig. 6B), the addition of
TNF-a + P. gingivalis LPS markedly
decreased phosphorylation of this
molecule compared to control, except
when FGF-2 was present: 0.08 
0.01, 0.21  0.08, 0.68  0.07 and
0.81  0.05 (p < 0.001, p < 0.001,
p < 0.046 and p = 0.184; T + L, T +
L + P100, T + L + P50 and T +
L + FGF-2, respectively; Fig. 6C).
When compared to TNF-a + P. gingi-
valis LPS, only the addition of perio-
stin 50 ng/mL (p < 0.005) and FGF-2
(p < 0.002) signiﬁcantly increased
phosphorylation of AKT (Fig. 6C).
Interestingly, phosphorylation of pro-
tein S6 was signiﬁcantly higher than
in the control group only with the
addition of periostin or FGF-2:
1.3  0.19, 2.71  0.1, 4.68  0.08
and 7.66  0.3 (p = 0.287, p < 0.001,
p < 0.001 and p < 0.001; T + L,
T + L + P100, T + L + P50 and T +
L + FGF-2, respectively; Fig. 6D).
When compared to TNF-a + P. gingi-
valis LPS alone, the addition of perio-
stin 100 ng/mL (p < 0.002), periostin
50 ng/mL (p < 0.001) and FGF-2
(p < 0.001) signiﬁcantly increased
phosphorylation of protein S6
(Fig. 6D).
Discussion
Regeneration of the tooth-supporting
apparatus has become a major chal-
lenge in dentistry (20) as well as a
highly demanded treatment due to the
high prevalence and impact that peri-
odontal diseases have in the daily
periodontal practice (3). Periostin is
primarily expressed by PDL ﬁbro-
blasts (8). It is localized between the
cytoplasmic processes of periodontal
ﬁbroblasts and cementoblasts and the
adjacent collagen ﬁbers (21). Periostin
is required for the integrity and
homeostasis of the PDL under normal
physiological occlusal load (2,9,10).
When not present or reduced, peri-
odontal tissues break down, possibly
due to the reduction on collagen ﬁber
diameter and the subsequent tissue
strength degradation (12). Within the
context of periodontal disease, perio-
stin is reduced by the eﬀect of inﬂam-
matory cytokines and bacterial
virulence factors (13) and it is inver-
sely related to the extent of bone alve-
olar loss (14). Therefore, restoration
of proper levels of this molecule in
the PDL environment may have a key
implication in the restoration of its
original structure and function.
Periostin has been previously
shown to increase cell survival and
proliferation rates in diﬀerent tissues,
including skin (16) and heart
(15,22,23). It plays a role in angiogen-
esis (24). Higher levels have been
reported as key in cancer develop-
ment, proliferation and metastasis
(25,26). Such eﬀects of periostin are
mediated by integrins avb1, avb3 and
avb5-integrins (17,27), which further
activate the downstream cascade of
the PI3K/AKT signaling pathway to
induce cell proliferation, as well as
phosphorylation of FAK to induce
cell migration (18). Our results in
A B
Fig. 2. Migration analysis under non-challenged conditions. (A) Representative images of hPDL migration under diﬀerent conditions and
time points. Original magniﬁcation: 49. Scale bar: 500 lm. (B) Scratched area over time for the diﬀerent culture conditions. Note the sig-
niﬁcantly faster area reduction compared to control (solid blue line) after treatment with periostin 100 ng/mL (dotted green line), FGF-2
(dotted purple line), and especially at earlier time points, with periostin 50 ng/mL (dotted orange line). n = 216 (four conditions, two cell
lines, three experiments, triplicates per condition, three images per replicate). FGF, ﬁbroblast growth factor; hPDL, human periodontal
ligament.
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A B
Fig. 4. Ki67 proliferation analysis under challenged conditions (addition of TNF-a + P. gingivalis LPS). (A) Representative image show-
ing total cell number per image (DAPI in blue) and Ki67-positive cells (green). Original magniﬁcation: 209. Scale bar = 50 lm. (B) Rela-
tive values of Ki67-positive cell percentages per group normalized to control (blue). Note the decrease after adding TNF-a + P. gingivalis
LPS (red; not statistically signiﬁcant) and the approximately 1.5-fold increase when adding periostin 100 ng/mL (green), 50 ng/mL
(orange) and FGF-2 (purple). p-values compared to control: *p < 0.022. p-values compared to TNF-a + P. gingivalis LPS: +p < 0.008.
n = 216 (four conditions, two cell lines, three experiments, triplicates per condition, three images per replicate). FGF, ﬁbroblast growth
factor; hPDL, human periodontal ligament; LPS, lipopolysaccharide; TNF, tumor necrosis factor.
A
B C D
Fig. 3. Western blot evaluation of non-challenged conditions and relative values of signal intensities compared to the control condition.
(A) Western blot images showing the activation of the PI3K/AKT/mTOR signaling pathway. (B) Total AKT semiquantiﬁcation reﬂects
an increase of this molecule in periostin and FGF-2 groups. p < 0.049. (C) Phosphorylation of AKT signiﬁcantly increases in the presence
of periostin 50 ng/mL (p < 0.011) and FGF-2 (p < 0.022). (D) Phosphorylation of protein S6 signiﬁcantly increases in the presence of
periostin 50 ng/mL or FGF-2, compared to either control or periostin 100 ng/mL (p < 0.001). FGF, ﬁbroblast growth factor.
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hPDL cells show high similarities with
previous reports. The present study
conﬁrms a PI3K/AKT-dependent migra-
tion and proliferation signaling
cascade activated by periostin toward
phosphorylation of the ribosomal
protein S6, the ﬁnal step of the
mTORC1 pathway after activation of
p70-S6 Kinase 1 (S6K1), especially
with lower dose (50 ng/mL) (Fig. 3)
(28). In fact, in terms of cell prolifera-
tion, as analyzed by Ki67 immunoﬂu-
orescence staining, periostin was able
to double the proliferation rate as
similar to that achieved by the posi-
tive control FGF-2 (Fig. 1); in terms
of cell migration, periostin was able
to accelerate wound closure even fas-
ter than the positive control FGF-2
(Fig. 2).
On the other hand, the eﬀects of
P. gingivalis LPS and TNF-a have
been also studied. A summative eﬀect
between both factors has been exten-
sively studied (29–32). LPS can
directly induce cell death or apoptosis
in many cell types, including macro-
phages, vascular endothelial cells, he-
patocytes and myocytes. In contrast,
LPS has an anti-apoptotic eﬀect on
neutrophils both in vivo and in vitro
(31). In a similar way, it is commonly
accepted that members of the TNF
superfamily mediate either prolifera-
tion, survival or apoptosis of cells
(33). Furthermore, during the inﬂam-
matory process, TNF-a, mediated or
not by LPS, also stimulates the
release of matrix metalloproteinases
and other products that enhance tis-
sue destruction (31). Previous studies
have also shown an indirect eﬀect of
bacterial LPS on apoptosis of PDL
cells through the induction of TNF-a
production (31) and TNFR1 (34).
Within the context of the present
study, we have observed a reduction
in proliferation by the eﬀects of
P. gingivalis LPS and TNF-a com-
bined, although the diﬀerences were
not statistically signiﬁcant. This
apparent discrepancy might be due to
speciﬁc characteristics of the experi-
ments to detect Ki67 in terms of cell
conﬂuence and duration of the expo-
sure to that challenge. Interestingly,
and important within the context of
periodontal regeneration, in a chal-
lenged situation, the addition of
periostin promoted cell proliferation
to a similar level as FGF-2 (Fig. 4),
but not as much as the eﬀects
achieved when P. gingivalis LPS and
TNF-a were not present (Fig. 1); the
eﬀect seems to be reduced (possible
competition with TNF-a/LPS), but
not completely cancelled.
It is interesting that phosphoryla-
tion of AKT and protein S6 with the
addition of periostin 100 ng/mL is
actually decreased under non-chal-
lenged conditions. The reason for this
is not clear at this moment but we
can speculate that higher doses of
periostin may actually exert a limiting
or inhibitory eﬀect, as seen with other
molecules and growth factors such as
platelet-derived growth factor (35,36).
The fact that we observed other
eﬀects with that dose (Ki-67 and
migration), rather than contradict this
plausible explanation, suggests a pos-
sible supplementary mechanism diﬀer-
ent than that involving AKT and
PS6.
However, to achieve true periodon-
tal regeneration, not only prolifera-
tion is needed. Migration of the
appropriate cells into the healing area
is key during the initial phases. PDL
cells are capable of diﬀerentiating
into cementogenic or osteogenic line-
age cells (37–39). Therefore, PDL
A B
Fig. 5. Migration analysis under challenged conditions. (A) Representative images of hPDL migration under diﬀerent conditions and time
points. Original magniﬁcation: 49. Scale bar: 500 lm. (B) Scratched area over time for the diﬀerent culture conditions. Note the signiﬁ-
cantly slower area reduction caused by the combined eﬀect of TNF-a+P. gingivalis LPS (solid red line) compared to non-challenged control
(solid blue line). Also, note the signiﬁcantly faster area reduction compared to TNF-a+P. gingivalis LPS after treatment with periostin
100 ng/mL (dotted green line), periostin 50 ng/mL (dotted orange line) and FGF-2 (dotted purple line). Area reduction was initially faster
for both periostin treatments, but after 12–18 h only FGF-2 and periostin 50 ng/mL accelerate hPDL migration at a higher rate comparable
to non-challenged control. n = 216 (four conditions, two cell lines, three experiments, triplicates per condition, three images per replicate).
FGF, ﬁbroblast growth factor; hPDL, human periodontal ligament; LPS, lipopolysaccharide; TNF, tumor necrosis factor.
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cells are essential not only for the
maintenance but also for regeneration
of the periodontium (40). hPDL cell
migration in the present study was
signiﬁcantly increased by periostin at
50 ng/mL, even at very early time
points (Fig. 2). Furthermore, in a
context of disease-simulated condi-
tions, with the addition of TNF-a
and P. gingivalis LPS, hPDL migra-
tion was signiﬁcantly reduced (Fig. 5).
In this challenged scenario, periostin
recovered the migration potential of
hPDL cells to levels not signiﬁcantly
diﬀerent as those achieved with the
addition of the positive control FGF-
2 or the non-challenged control
group. These are key mechanisms, as
occupying the space with this speciﬁc
cell population with multipotent
capacities (PDL cells) could lead to
the regeneration of the area reducing
the chances of formation of repara-
tive tissues.
FGF-2, used in this study as posi-
tive control, has been used, among
other applications, in clinical studies
for periodontal tissue regeneration
(41,42) due to the activation of a
plethora of cellular events: prolifera-
tive responses of PDL cells through
the extracellular signal-regulated
kinase (ERK) 1/2 signaling molecule
(43,44), cell migration via PI3K/AKT
signaling (44,45), and regulatory
eﬀects of ECM production and PDL
cell diﬀerentiation (46). FGF-2 seems
to act on immature PDL cells to
stimulate proliferation while suppress-
ing diﬀerentiation into hard tissue-
forming cells. During the subsequent
healing processes, PDL cells begin to
diﬀerentiate, inducing periodontal tis-
sue regeneration (46). In contrast, dif-
ferent studies have shown that
FGF-stimulated eﬀects are partially
inhibited by TNF-a (47).
The eﬀects achieved in this study
with the application of FGF-2 are
comparable to those obtained with
periostin. Therefore, periostin may
become a promising agent in
periodontal regeneration with some
important advantages as it integrates
a spectrum of key events in matrix–
cellular interactions: accelerates hPDL
cell migration, favors hPDL cell
A
B C D
Fig. 6. Western blot evaluation of challenged conditions and relative values of signal intensities compared to the control condition. (A)
Western blot images showing the activation of the PI3K/AKT/mTOR signaling pathway. (B) Total AKT semiquantiﬁcation reﬂects an
increase of this molecule for all groups compared to control (p < 0.003). C) Compared to control, phosphorylation of AKT is signiﬁcantly
lower in the presence of TNF-a and P. gingivalis LPS (p < 0.001) even with the addition of periostin 100 ng/mL (p < 0.001) or periostin
50 ng/mL (p < 0.046). Compared to TNF-a and P. gingivalis LPS, phosphorylation of AKT is signiﬁcantly higher in the presence of
periostin 50 ng/mL (p < 0.005) or FGF-2 (p < 0.002). D) Phosphorylation of protein S6 signiﬁcantly increases only in the presence of
periostin or FGF-2, compared to either control or TNF-a and P. gingivalis LPS (p < 0.001). FGF, ﬁbroblast growth factor; hPDL,
human periodontal ligament; LPS, lipopolysaccharide; TNF, tumor necrosis factor.
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proliferation, promotes angiogenesis
and, ﬁnally and decisively, will pro-
mote a mechanically stable ECM suit-
able to support periodontal tissue
stability with a higher speciﬁcity for
the PDL.
Migration and proliferation, although
related, are diﬀerent processes. Study-
ing these processes in vitro is compli-
cated. Therefore, further studies to
conﬁrm the optimum concentration
for each process and the combination
of both are needed as well as in vivo
studies to conﬁrm these observations.
Conclusion
Periostin, a key factor for periodontal
integrity, is involved in important cel-
lular events, such as cell proliferation,
migration and activation of the sur-
vival signaling pathway PI3K/AKT/
mTOR. Such eﬀects may support the
use of periostin as a novel biological
agent for periodontal regeneration
purposes. Further studies of the spe-
ciﬁc mechanisms, protein concentra-
tions, timely assessment and the
regenerative value of periostin in ani-
mal studies are needed.
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